Xencor Inc — Director's Dealing 2013

Dec 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2013-12-06

Reporting Person: SARAN ATUL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-06	Common Stock	C	1319522	—	Acquired	1319522	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-06	Series A-1 Preferred Stock	$	C	4090519	Disposed		Common Stock (1319522)	Indirect

Footnotes

F1: Every 3.1 shares of the Series A-1 Preferred Stock is convertible into 1 share of the Issuer's Common Stock at any time, at the holder's election, and has no expiration date.

F2: These securities are held of record by MedImmune Ventures, Inc. ("MedImmune"). The Reporting Person is the chairperson of the six-person investment committee of MedImmune. The Reporting Person disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein.